Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al

Interaction of SARS-CoV-2 proteins with specific host cellular targets could rewire sugar-, AA-, FA-, as well as nucleotide-metabolism(s), and distinctly alter or impair bioenergetics, immune response, and redox homeostasis in the human body, thereby facilitate viral life cycle 21,22
99%+ Purity HPLC Tested LC-MS Verified Research Use Only Research Applications Dihexa has been investigated in published scientific literature involving peptide chemistry, molecular biology, receptor interactions, protein expression, cellular signaling pathways, and experimental laboratory research
If youre exploring additional stacking, review the advanced hub first at Advanced BPC-157 TB-500 Protocols: Timing, Stacking & 2025 Optimization, and then only consider add-ons if you have a clear purpose and a stable baseline